EGATEN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Jun 2025)
What this means for you
Registered since 30 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86898493
- Registration number
- 5822083
- Mark type
- Stylized text
- Filed
- 05 Feb 2016
- Published for opposition
- 12 Jul 2016
- Registered
- 30 Jul 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, an anti-helminthic
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 04 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 May 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 26 May 2025 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 26 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Feb 2025 — TEAS SECTION 8 & 15 RECEIVED
- 30 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 25 Jun 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Jun 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 May 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 27 May 2019 — USE AMENDMENT FILED
- 27 May 2019 — TEAS STATEMENT OF USE RECEIVED
- 09 Mar 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Mar 2019 — SOU EXTENSION 5 GRANTED